Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies
Overexpression of SNCA has been implicated in the pathogenesis of synucleinopathies, particularly Parkinson's disease (PD) and dementia with Lewy bodies (DLB). While PD and DLB share some clinical and pathological similarities, each disease presents distinct characteristics, including the prima...
Saved in:
Main Authors: | Zhiguo Sun (Author), Boris Kantor (Author), Ornit Chiba-Falek (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
by: Julia Gamache, et al.
Published: (2020) -
Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in Neurodegeneration
by: Lucia Yi-Ru Chung, et al.
Published: (2022) -
DEVELOPMENT OF MURINE STEM CELLS WITH CONDITIONAL KNOCKOUT OF HUMANIZED SNCA GENE
by: E. A. Patrakhanov, et al.
Published: (2023) -
The Pharmacology of Visual Hallucinations in Synucleinopathies
by: Mirella Russo, et al.
Published: (2019) -
The Potential of iPS Cells in Synucleinopathy Research
by: Leonhard Linta, et al.
Published: (2012)